54.26
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BBIO Giù?
Forum
Previsione
Bridgebio Pharma Inc Borsa (BBIO) Ultime notizie
Real time alert setup for BridgeBio Pharma Inc. performanceWeekly Trend Summary & Low Risk High Win Rate Stock Picks - newser.com
Will BridgeBio Pharma Inc. stock pay special dividendsEarnings Summary Report & Free AI Powered Buy and Sell Recommendations - newser.com
How BridgeBio Pharma Inc. (2CL) stock reacts to fiscal policiesJuly 2025 Selloffs & Fast Entry and Exit Trade Plans - newser.com
What indicators show strength in BridgeBio Pharma Inc.Fed Meeting & Real-Time Chart Pattern Alerts - newser.com
Why retail investors favor BridgeBio Pharma Inc. stock2025 Breakouts & Breakdowns & Low Risk Investment Opportunities - newser.com
BridgeBio to Report Phase 3 Results for Small Molecule BBP-418 in LGMD2I/R9 FORTIFY Study, along with Third Quarter 2025 Financial Results Next Week - The Manila Times
BridgeBio (NASDAQ: BBIO) to present FORTIFY interim topline Oct. 27; earnings Oct. 29 - Stock Titan
Is BridgeBio Pharma Inc. stock supported by strong fundamentalsJuly 2025 Selloffs & AI Enhanced Trading Alerts - newser.com
Will BridgeBio Pharma Inc. (2CL) stock outperform value peersQuarterly Trade Review & Entry and Exit Point Strategies - newser.com
What analysts say about BridgeBio Pharma Inc stockStop Loss Placement Tips & Small Investment Capital Tips - earlytimes.in
Sentiment analysis tools applied to BridgeBio Pharma Inc.2025 Support & Resistance & Fast Gain Swing Alerts - newser.com
BridgeBio Pharma Inc. stock trend outlook and recovery path2025 Technical Patterns & Entry and Exit Point Strategies - newser.com
Leading vs lagging indicators on BridgeBio Pharma Inc. performance2025 AllTime Highs & Daily Volume Surge Signals - newser.com
Long term hold vs stop loss in BridgeBio Pharma Inc.July 2025 Retail & Free High Return Stock Watch Alerts - newser.com
Using economic indicators to assess BridgeBio Pharma Inc. potentialChart Signals & Weekly High Return Stock Opportunities - newser.com
BridgeBio Pharma stock rating reiterated as Overweight by Wells Fargo - Investing.com Canada
BridgeBio (BBIO) Tanks After Selling Beyonttra Royalty Rights - MSN
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):